Oramed appoints Benjamin Shapiro to Board of Directors effective May 1, 2023

ORAMED PHARMACEUTICALS INC.

Board size increased by one; Benjamin Shapiro appointed to fill vacancy effective May 1, 2023.
Shapiro co-founded The Daily Wire, hosts 'The Ben Shapiro Show', and holds a J.D. from Harvard Law.
Compensation for Shapiro will be the same as for other non-executive directors.
No arrangements or related-party transactions requiring disclosure under Item 404(a) exist.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Benjamin Shapiro

Director

ORMP · ORAMED PHARMACEUTICALS INC.

Effective: 2023-05-01
Filed: May 1, 2023, 7:59 PM ET

On April 27, 2023, Oramed Pharmaceuticals Inc. (the “Company”) increased the size of its Board of Directors (the “Board”) by one and appointed Mr. Benjamin Shapiro to serve as a director to fill the resulting vacancy, effective as of May 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Benjamin Shapiro was appointed as Director at ORAMED PHARMACEUTICALS INC..

Action: appointed
Role: Director

Exact text from the filing

On April 27, 2023, Oramed Pharmaceuticals Inc. (the “Company”) increased the size of its Board of Directors (the “Board”) by one and appointed Mr. Benjamin Shapiro to serve as a director to fill the resulting vacancy, effective as of May 1, 2023.

View on SEC.gov

ORAMED PHARMACEUTICALS INC. filing history →

Source: SEC EDGAR

accession 0001213900-23-034728

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.